Cargando…

Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab

Among the IL-6 inhibitors, tocilizumab is the most widely used therapeutic option in patients with SARS-CoV-2-associated severe respiratory failure (SRF). The aim of our study was to provide evidence on predictors of poor outcome in patients with COVID-19 treated with tocilizumab, using machine lear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramón, Antonio, Zaragozá, Marta, Torres, Ana María, Cascón, Joaquín, Blasco, Pilar, Milara, Javier, Mateo, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410189/ https://www.ncbi.nlm.nih.gov/pubmed/36012968 http://dx.doi.org/10.3390/jcm11164729

Ejemplares similares

A Machine Learning-Based Method for Detecting Liver Fibrosis
por: Suárez, Miguel, et al.
Publicado: (2023)

Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach
por: Suárez, Miguel, et al.
Publicado: (2023)

Predictive Model for Mortality in Severe COVID-19 Patients across the Six Pandemic Waves
por: Casillas, Nazaret, et al.
Publicado: (2023)

Predictors of Mortality in Tocilizumab-Treated Severe COVID-19
por: Pagkratis, Konstantinos, et al.
Publicado: (2022)

Method for Classifying Schizophrenia Patients Based on Machine Learning
por: Soria, Carmen, et al.
Publicado: (2023)

Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab
por: Salvati, Lorenzo, et al.
Publicado: (2020)

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
por: Rosas, Ivan O., et al.
Publicado: (2021)

Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia
por: Górgolas Hernández-Mora, Miguel, et al.
Publicado: (2021)

Comparative Study of Several Machine Learning Algorithms for Classification of Unifloral Honeys
por: Mateo, Fernando, et al.
Publicado: (2021)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
por: Rubio-Rivas, Manuel, et al.
Publicado: (2020)

Tocilizumab in HIV patient with severe COVID-19: case report
por: Bertozzi, Pedro Vieira, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya
por: Shah, Reena, et al.
Publicado: (2022)

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report
por: Boistault, Margaux, et al.
Publicado: (2021)

Tocilizumab is recommended for the treatment of severe COVID-19
por: Zhou, Yonggang, et al.
Publicado: (2020)

Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Fioravanti, Antonella, et al.
Publicado: (2020)

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016)

COVID-19 Induced Cardiomyopathy Successfully Treated with Tocilizumab
por: Schreiber, Ariyon, et al.
Publicado: (2022)

COVID-19 INDUCED CARDIOMYOPATHY SUCCESSFULLY TREATED WITH TOCILIZUMAB
por: Fakhra, Sadaf, et al.
Publicado: (2022)

Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
por: Kalligeros, Markos, et al.
Publicado: (2022)

A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital
por: AlBahrani, Salma, et al.
Publicado: (2021)

Severe Adult Still's Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
por: Akiyama, Kaho, et al.
Publicado: (2021)

Characteristics of the First 102 Severe COVID-19 Cases Treated With Convalescent Plasma or Tocilizumab or Both in Al-Nahdha Hospital, Oman
por: Al Harthi, Saud, et al.
Publicado: (2021)

Impact of tocilizumab administration on mortality in severe COVID-19
por: Tsai, Andrew, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Effective treatment of severe COVID-19 patients with tocilizumab
por: Xu, Xiaoling, et al.
Publicado: (2020)

Tocilizumab in severe COVID-19: A promise fulfilled
por: Levi, Marcel
Publicado: (2022)

Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients
por: Wang, Yong, et al.
Publicado: (2022)

Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19
por: Hong, Jin Yeong, et al.
Publicado: (2022)

509. A Comparison of Tocilizumab and Baricitinib for Hospitalized Patients with Severe COVID-19
por: Aytoda, Priyanka, et al.
Publicado: (2023)

Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2022)

Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2022)

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
por: Stone, John H., et al.
Publicado: (2020)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5hv311j1pvrvmh10497u6ju5f1